Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 941-950 of 969 for hematology

Edit search filters
  1. A Study of the Natural History of Monoclonal Gammopathy of Undetermined Significance (MGUS) Over Time

    Rochester, MN

  2. Developing Criteria for Treatment of Neurofibromatosis Type 1 Associated Optic Pathway Glioma

    Rochester, MN

  3. Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

    Jacksonville, FL, Rochester, MN

  4. DNA Damage Using hERY-MNT Technology can Predict Chemotherapy Induced Toxicity in Women with Ovarian Cancer

    Rochester, MN

  5. Determining if a PET/MRI can predict complete response from chemoradiotherapy before surgery in patients with locally advanced rectal cancer

    Rochester, MN

  6. In Vitro Studies in Cold Agglutinin Disease

    Rochester, MN

  7. Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of Sulfonamide Allergy

    Rochester, MN

  8. Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)

    Rochester, MN

  9. Study of Late-Occurring Complications in Childhood Cancer Survivors

  10. A Study to Assess Older Adults Applying Pre-transplant Comorbidity, Geriatric Assessment and Biomarkers to Predict Non-Relapse Mortality After Allogeneic Transplant (CHARM)

    Rochester, MN, Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer